Eric J. Foss
Eric J. Foss's purchase track record
Eric J. Foss has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/10/2026 | PRMB | $2.00M | pending | pending | — |
| 11/11/2025 | PRMB | $1.99M | +22.7% | +53.1% | +8.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Cigna Shifts Strategy Toward Health Technology With Health Sense Initiative. Cigna is repositioning its competitive advantage through the Health Sense platform, signaling a move toward data-driven care delivery. The company's trailing P/E of 12.1 and 1.74% dividend yield highlight its value profile. Analysts project an average target of $342.29, while the 52-week range spans $239.51 to $311.34. Current support at $279.02 has seen 11 touches, suggesting caution ahead of potential moves.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
UBS Downgrades O-I Glass to Neutral, Cuts Price Target to $6. UBS has downgraded O-I Glass to Neutral and lowered its price target to $6. This move places the new target near the bottom of the current analyst range. The stock is currently trading with an RSI of 28.7, indicating it is in oversold territory.
Transaction History
| PRMB | ▲ Buy | Open Market | 100 | $2K | 8/10/2026 | View on chart |
| PRMB | ▲ Buy | Open Market | 83,900 | $2.0M | 8/10/2026 | View on chart |
| CI | ▲ Buy | Grant | 782 | $0 | 4/22/2026 | View on chart |
| PRMB | ▲ Buy | Grant | 129,770 | $0 | 12/10/2025 | View on chart |
| PRMB | ▲ Buy | Open Market | 4,970 | $80K | 11/12/2025 | View on chart |
| PRMB | ▲ Buy | Open Market | 123,049 | $1.9M | 11/11/2025 | View on chart |
| PRMB | ▲ Buy | Grant | 207,468 | $0 | 11/7/2025 | View on chart |
| OI | ▲ Buy | Grant | 11,713 | $0 | 5/15/2025 | View on chart |
| PRMB | ▲ Buy | Grant | 5,317 | $0 | 5/1/2025 | View on chart |
| CI | ▲ Buy | Grant | 638 | $0 | 4/23/2025 | View on chart |
| PRMB | ▲ Buy | Grant | 787 | $19K | 11/8/2024 | View on chart |
| OI | ▲ Buy | Grant | 10,933 | $0 | 5/16/2024 | View on chart |
| CI | ▲ Buy | Grant | 539 | $0 | 4/24/2024 | View on chart |
| CI | ▲ Buy | Grant | 765 | $0 | 4/26/2023 | View on chart |
| CI | ▲ Buy | Grant | 757 | $0 | 4/27/2022 | View on chart |
| CI | ▲ Buy | Grant | 199 | $0 | 2/28/2022 | View on chart |
| CI | ▲ Buy | Grant | 247 | $0 | 11/30/2021 | View on chart |
| CI | ▲ Buy | Grant | 224 | $0 | 8/31/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Primo Brands Premium Water Growth Draws Market Attention
Recent reports highlight Primo Brands' 30.5% growth in its premium water segment, raising questions about the sustainability of this momentum. The company trades at a trailing P/E of 70.4, which is notably high, while the stock currently sits near its 52-week low of $14.36. Analysts maintain an average price target of $30.27, suggesting a significant gap between current market sentiment and long-term expectations.
Primo Brands Premium Water Growth Draws Market Attention. Recent reports highlight Primo Brands' 30.5% growth in its premium water segment, raising questions about the sustainability of this momentum. The company trades at a trailing P/E of 70.4, which is notably high, while the stock currently sits near its 52-week low of $14.36. Analysts maintain an average price target of $30.27, suggesting a significant gap between current market sentiment and long-term expectations.